melanocortin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-02. Numbers and descriptions here follow the published literature rather than marketing material.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Retention time supports identity, while the mass spectrum confirms the molecular weight of the intact peptide. Purity is frequently reported as a percentage of total peak area, a figure that depends on the wavelength, column and gradient used. Impurity profiling may also look for truncated sequences, oxidised forms and residual counterions. Amino acid analysis and peptide mapping provide orthogonal confirmation when required.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid in a sealed vial |
| Solubility class | Soluble in water and polar organic solvents | Reconstituted solutions are generally clear |
| Typical storage temperature | -20 degrees Celsius or below, dry | Protect from light; avoid repeated freeze-thaw cycles |
| Common analytical methods | Reversed-phase HPLC-UV, LC-MS | Used for purity estimation and mass confirmation |
| Reported purity range | Area percentage above 95 percent | Reporting practice and acceptance limits differ by laboratory |
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.
Darren Millar is elected unopposed as leader of the Welsh Conservatives following the resignation of Andrew RT Davies. 6 December – Keir Starmer becomes the third UK prime minister to attend a meeting of the British-Irish Council in 17 years. First Minister of Scotland John Swinney and Prime Minister Keir Starmer hold private talks about the Scottish Government's plans to scrap the two child benefit cap, which are later described as "helpful". Labour MPs Jeevun Sandher and Louise Jones announce their engagement. Dave Penman, general secretary of the FDA union, accuses the prime minister of using "Trumpian language" in his criticism of the civil service. The Labour leader of Bolsover District Council, Steve Fritchley, is cleared over accusations of homophobia. Conservative peer Lord Rami Ranger is stripped of his CBE after a report by the Parliamentary Commission for Standards found he harassed and bullied a journalist via social media. 7 December – Prince William meets US president-elect Donald Trump for talks while visiting France to attend the reopening of Notre-Dame Cathedral. 8 December – Prime Minister Sir Keir Starmer welcomes the Fall of the Assad regime in Syria, which he describes as "barbaric", and calls for the restoration of "peace and stability". Scottish Labour suspends Cammy Day, the leader of Edinburgh City Council, pending the outcome of a police investigation into alleged inappropriate behaviour.
Mike Evans tied the record for consecutive seasons with at least 1,000 receiving yards, with 11. He shares this record with Jerry Rice. Evans also extended his own record of most such seasons to start his career. Aaron Rodgers became the fifth player to have 500 passing touchdowns. Trey McBride set the record for most receptions by a tight end in his first three seasons, with 221. The previous record of 216 was held by George Kittle. The Buffalo Bills became the first team to score at least 30 rushing touchdowns and at least 30 passing touchdowns in a season. Wild Card Round
In 1949, Glenn T. Seaborg, who devised the actinide concept, predicted that element 103 (lawrencium) should be the last actinide and that the Lr3+ ion should be about as stable as Lu3+ in aqueous solution. It was not until decades later that element 103 was finally conclusively synthesized and this prediction was experimentally confirmed. Studies on the element, performed in 1969, showed that lawrencium reacts with chlorine to form a product that was most likely the trichloride, LrCl3. Its volatility was found to be similar to the chlorides of curium, fermium, and nobelium and much less than that of rutherfordium chloride. In 1970, chemical studies were performed on 1500 atoms of 256Lr, comparing it with divalent (No, Ba, Ra), trivalent (Fm, Cf, Cm, Am, Ac), and tetravalent (Th, Pu) elements. It was found that lawrencium coextracted with the trivalent ions, but the short half-life of 256Lr precluded a confirmation that it eluted ahead of Md3+ in the elution sequence. Lawrencium occurs as the trivalent Lr3+ ion in aqueous solution and hence its compounds should be similar to those of the other trivalent actinides: for example, lawrencium(III) fluoride (LrF3) and hydroxide (Lr(OH)3) should both be insoluble in water. Due to the actinide contraction, the ionic radius of Lr3+ should be smaller than that of Md3+, and it should elute ahead of Md3+ when ammonium α-hydroxyisobutyrate (ammonium α-HIB) is used as an eluant.
=== Pharmaceuticals === Anticancer drugs that exert their pharmacological effect by interfering with menin's interactions include the approved drug revumenib and the experimental drugs bleximenib, enzomenib, icovamenib, and ziftomenib.
Sources: en.wikipedia.org
=== Temporal arteritis === About 20% of people who are diagnosed with polymyalgia rheumatica also have temporal arteritis (also called giant cell arteritis), and about 50% of people with temporal arteritis have polymyalgia rheumatica. Some symptoms of temporal arteritis include headaches, scalp tenderness, jaw or facial soreness, distorted vision, or aching in the limbs caused by decreased blood flow, and fatigue.
== Adverse effects == The exact incidence of the adverse effects of dexamethasone is not available, hence estimates have been made as to the incidence of the adverse effects below based on the adverse effects of related corticosteroids and on available documentation on dexamethasone.
Meyer (1940), composer, author, philosopher known for his contributions to the aesthetic theory of music Orrin Keepnews (1943), jazz record producer and winner of the 1988 Grammy Award for Best Album Notes and Best Historical Album Mort Lindsey (1944), musical director for Judy Garland and Merv Griffin Dick Hyman (1948), musical director for Arthur Godfrey; composer or arranger for Hannah and Her Sisters and The Purple Rose of Cairo; Emmy Award winner Philip Springer (1950), composer known for writing the song "Santa Baby" Randy Starr (1951), dentist and composer for Elvis Presley Eric Salzman (1954), composer, producer, critic; founder of the American Music Theater Festival and composer-in-residence of the Center for Contemporary Opera Malcolm Frager (1955), piano virtuoso Mike Berniker (1957), musical producer and winner of nine Grammy Awards Billy Goldenberg (1957), composer and winner of four Emmy Awards John Corigliano (1959), winner of the Pulitzer Prize for Music and Academy Award for Best Original Score Edward Kleban (1959), lyricist for A Chorus Line David Bromberg* (1960s), Grammy Award-nominated musician Art Rosenbaum (1960), Grammy Award-winning art professor and musician at Georgia State University Charles Wuorinen (1961), serialist composer and winner of the Pulitzer Prize for Music for Time's Encomium Charlie Morrow (1962), sound artist and musician Joel Krosnick (1963), chamber musician and member of the Juilliard String Quartet David Rubinson (1963), record and music producer of Apocalypse Now, founder of San Francisco Records and The Automatt recording studio Art Garfunkel (1965), singer of Simon and Garfunkel, famous for the song "The Sound of Silence" Daniel Waitzman (1965), flutist and composer Kenneth Ascher (1966), Academy Award-nominated jazz pianist; writer of "Rainbow Connection" from The Muppet Movie David Schiff (1967), composer Tom Werman (1967), former record producer for Epic Records Billy Cross (1968), guitarist, singer, and producer who lives in Denmark Jon Bauman (1969), "Bowzer" of Sha Na Na James "Plunky" Branch (1969), jazz musician Cameron Brown (1969), jazz bassist Emanuel Ax (1970), concert pianist Marc Copland (1970), jazz pianist and composer Scott Simon (1970), member of Sha Na Na Frederick "Dennis" Greene (1971), member of Sha Na Na; professor of law at the University of Dayton Armen Donelian (1972), jazz pianist Jocko Marcellino (1972), member of Sha Na Na Phil Schaap (1973), Charlie Parker authority and multiple Grammy Award winner for engineering, production, and album notes Eugene Drucker (1973), Grammy Award-winning violinist, member of the Emerson String Quartet Sam Morrison (1973), saxophonist Michael Jeffrey Shapiro (1973), composer and conductor Richard Einhorn (1975), composer, Voices of Light Phil Kline (1975), composer Paul Phillips (1978), conductor, composer, and music scholar at Brown University Erik Friedlander (1982), cellist, son of American photographer Lee Friedlander Robbie Fulks* (1984), Grammy Award-nominated American alternative country singer-songwriter Dave Nachmanoff (1986), award-winning folk singer and sideman to Al Stewart John Bohlinger (1988), musician and music director on NBC program Nashville Star Laura Cantrell (1989), country musician Peter J. Nash (1989), member of 3rd Bass Mac McCaughan (1990), member of indie rockband Superchunk and founder of Merge Records Richard Carrick (1993), pianist, composer, professor at Berklee College of Music Gil Shaham (1993), violinist Jefferson Friedman (1996), composer Tom Kitt (1996), composer, co-winner of the 2010 Pulitzer Prize for Drama and the Tony Award for Best Original Score for his score of the musical Next to Normal R. Luke DuBois (1997), composer and artist Lauryn Hill* (1997), Grammy Award-winning R&B singer and songwriter, and member of The Fugees Sean Lennon* (1997), singer and songwriter, and son of John Lennon and Yoko Ono Orli Shaham (1997), pianist Yelena Dudochkin (1998), Ukrainian-American soprano Scott Hoffman (1999), known by the stage name Babydaddy, member of the rock band Scissor Sisters The Two Man Gentlemen Band, modern musical duo that consists of Fuller Condon (2000) and Andy Bean (2001) Mason Bates (2000), Grammy Award-winning composer Tom Frank (2000), journalist, former member of indie-rock band Jonathan Fire*Eater Hikaru Utada* (2000), Japanese pop star Alicia Keys* (2001), Grammy Award-winning R&B singer and songwriter Brian Weitz (2001), founding member of experimental band Animal Collective Emily and Julia Bruskin (2002), members of the Claremont Trio Ken-David Masur (2002), musical director of the Milwaukee Symphony Orchestra, son of conductor Kurt Masur Ariana Ghez (2003), oboist Nico Muhly (2003), contemporary classical music composer Anna Bulbrook (2004), violinist formerly member of indie band The Airborne Toxic Event Alisa Weilerstein (2004), cellist and 2011 MacArthur Fellow Tristan Perich (2004), contemporary composer and sound artist Peter Cincotti (2005), pianist Ellen Reid (2005), composer and recipient of the 2019 Pulitzer Prize for Music Patrick Higgins (2006), composer, musician, producer Michael Barimo (2006), pop singer and whistler Rostam Batmanglij (2006), member of alt-rock band Vampire Weekend Ezra Koenig (2006), member of alt-rock band Vampire Weekend Chris Tomson (2006), member of alt-rock band Vampire Weekend Chris Baio (2007), member of alt-rock band Vampire Weekend Call Me Ace or Anthony Patterson (2011), rapper Adam Met (2013), member of pop band AJR Danny Mercer (2013), singer, songwriter and producer Nathan Chan (2014), cellist Conrad Tao (2015), composer, pianist, violinist Jack Met* (2019), member of pop band AJR Maude Latour (2022), singer-songwriter Annie Moon (2026), member of a co-ed K-Pop Group ALLDAY PROJECT
Sources: en.wikipedia.org
== Cross-Linked Enzyme Aggregates (CLEAs) == The use of cross-linked enzyme crystals (CLECs) as industrial biocatalysts was pioneered by Altus Biologics in the 1990s. CLECs proved to be significantly more stable to denaturation by heat, organic solvents and proteolysis than the corresponding soluble enzyme or lyophilized (freeze-dried) powder. CLECs are robust, highly active immobilized enzymes of controllable particle size, varying from 1 to 100 micrometer. Their operational stability and ease of recycling, coupled with their high catalyst and volumetric productivities, renders them ideally suited for industrial biotransformations. However, CLECs have an inherent disadvantage: enzyme crystallization is a laborious procedure requiring enzyme of high purity, which translates to prohibitively high costs. The more recently developed cross-linked enzyme aggregates (CLEAs), on the other hand, are produced by simple precipitation of the enzyme from aqueous solution, as physical aggregates of protein molecules, by the addition of salts, or water miscible organic solvents or non-ionic polymers. The physical aggregates are held together by covalent bonding without perturbation of their tertiary structure, that is without denaturation. Subsequent cross-linking of these physical aggregates renders them permanently insoluble while maintaining their pre-organized superstructure, and, hence their catalytic activity. This discovery led to the development of a new family of immobilized enzymes: cross-linked enzyme aggregates (CLEAs).
Making models out of clay before beginning to build, the city planners remained consistent with Inca architecture and laid out a city that separated the agriculture and urban areas. Before construction began the engineers had to assess the spring and whether it could provide for all of the city’s anticipated citizens. After evaluating the water supply, the civil engineers designed a 2,457-foot (749 m)-long canal to what would become the city’s center. The canal descends the mountain slope, enters the city walls, passes through the agricultural sector, then crosses the inner wall into the urban sector, where it feeds a series of fountains. The fountains are publicly accessible and partially enclosed by walls that are typically about 1.2 m high, except for the lowest fountain, which is a private fountain for the Temple of the Condor and has higher walls. At the head of each fountain, a cut stone conduit carries the water to a rectangular spout, which is shaped to create a jet of water suitable for filling aryballos–a typical Inca clay water jug. The water collects in a stone basin in the floor of the fountain, then enters a circular drain that delivers it to the approach channel for the next fountain. The Incas built the canals on steady grades, using cut stones as the water channels. Most citizens worked on the construction and maintenance of the canal and irrigation systems, bronze and stone tools to complete the water-tight stone canals.
Each country has its own laws and regulations for the import and export of goods into and out of a country, which its customs authority enforces. The import or export of certain goods may be restricted or prohibited, in which case customs controls enforce these policies. Customs enforcement at borders can also entail collecting excise tax and preventing the smuggling of dangerous or illegal goods. A customs duty is a tariff or tax on the importation (usually) or exportation (unusually) of goods. In many countries, border controls for arriving passengers at many international airports and some road crossings are separated into red and green channels to prioritise customs enforcement. Within the European Union's common customs area, airports may operate additional blue channels for passengers arriving from within that area. For such passengers, border control may focus specifically on prohibited items and other goods that are not covered by the common policy. Luggage tags for checked luggage travelling within the EU are green-edged to facilitate identification. In most EU member states, travellers coming from other EU countries within the Schengen Area can use the green lane. However, airports outside the Schengen Area, or those with frequent flights arriving from jurisdictions within the Schengen Area but outside the European Union, may use blue channels for convenience and efficiency. A customs area is a designated area for storing commercial goods that have not cleared border controls.
phosphate backbone Also phosphodiester backbone, sugar–phosphate backbone, and phosphate–sugar backbone. The linear chain of alternating phosphate and sugar compounds that results from the linking of consecutive nucleotides in the same strand of a nucleic acid molecule, and which serves as the structural framework of the nucleic acid. Each individual strand is held together by a repeating series of phosphodiester bonds connecting each phosphate group to the ribose or deoxyribose sugars of two adjacent nucleotides. These bonds are created by ligases and broken by nucleases.
Sources: en.wikipedia.org
The dry powder is more stable during transport and storage than a solution. It also allows a known amount of material to be reconstituted at a chosen concentration.
Most certificates state a percentage derived from chromatographic peak area, alongside a mass confirmation. The exact criteria and acceptance thresholds vary between laboratories.
Dry powder is kept frozen or refrigerated and protected from light and moisture. Solutions are handled cold and used promptly to limit degradation.
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.